Bellevue Group
Latest statistics and disclosures from Bellevue Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IONS, ARGX, NBIX, VRTX, ISRG, and represent 23.10% of Bellevue Group's stock portfolio.
- Added to shares of these 10 stocks: DXCM (+$43M), COO (+$40M), SAGE (+$18M), SIBN (+$17M), STE (+$17M), BEAM (+$17M), CLDX (+$16M), ANNX (+$16M), ESPR (+$15M), GPCR (+$15M).
- Started 23 new stock positions in MLTX, MLYS, ANNX, COO, ASTH, BMY, BPMC, STE, AAPL, GRMN. TEVA, WST, ADMA, RGNX, MDGL, SMPL, NEO, FDMT, OABI, BIDU, IDYA, GKOS, BAX.
- Reduced shares in these 10 stocks: AXNX (-$114M), ISRG (-$60M), NBIX (-$52M), Cooper Companies (-$33M), EVH (-$29M), VRTX (-$28M), ARGX (-$23M), MRNA (-$21M), APLS (-$20M), CRSP (-$19M).
- Sold out of its positions in AXNX, Cooper Companies, DVA, Inhibrx, MCHI, Karuna Therapeutics Ord, KOS, LTH, LULU, NKE. XOP, SUPN, GDXJ, WW, ZLAB.
- Bellevue Group was a net seller of stock by $-233M.
- Bellevue Group has $6.6B in assets under management (AUM), dropping by 0.30%.
- Central Index Key (CIK): 0001674546
Tip: Access up to 7 years of quarterly data
Positions held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Portfolio Holdings for Bellevue Group
Bellevue Group holds 169 positions in its portfolio as reported in the March 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ionis Pharmaceuticals (IONS) | 5.5 | $360M | -4% | 8.3M | 43.35 |
|
Argenx Se Sponsored Adr (ARGX) | 4.9 | $319M | -6% | 811k | 393.72 |
|
Neurocrine Biosciences (NBIX) | 4.3 | $284M | -15% | 2.1M | 137.92 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 4.3 | $280M | -9% | 669k | 418.01 |
|
Intuitive Surgical Com New (ISRG) | 4.2 | $272M | -18% | 682k | 399.09 |
|
Boston Scientific Corporation (BSX) | 3.3 | $216M | 3.1M | 68.49 |
|
|
Intra Cellular Therapies (ITCI) | 3.0 | $195M | -8% | 2.8M | 69.20 |
|
Moderna (MRNA) | 2.8 | $182M | -10% | 1.7M | 106.56 |
|
Dex (DXCM) | 2.6 | $169M | +33% | 1.2M | 138.70 |
|
Revolution Medicines (RVMD) | 2.5 | $164M | 5.1M | 32.23 |
|
|
Abbott Laboratories (ABT) | 2.5 | $163M | -6% | 1.4M | 113.66 |
|
Stryker Corporation (SYK) | 2.5 | $161M | -3% | 449k | 357.87 |
|
Macrogenics (MGNX) | 2.2 | $147M | 10M | 14.72 |
|
|
Alnylam Pharmaceuticals (ALNY) | 2.1 | $137M | +3% | 918k | 149.45 |
|
Incyte Corporation (INCY) | 1.9 | $123M | 2.2M | 56.97 |
|
|
Celldex Therapeutics Com New (CLDX) | 1.8 | $117M | +15% | 2.8M | 41.97 |
|
Agios Pharmaceuticals (AGIO) | 1.8 | $117M | 4.0M | 29.24 |
|
|
Edwards Lifesciences (EW) | 1.6 | $105M | +8% | 1.1M | 95.56 |
|
Becton, Dickinson and (BDX) | 1.6 | $103M | +7% | 416k | 247.45 |
|
Arvinas Ord (ARVN) | 1.5 | $99M | -4% | 2.4M | 41.28 |
|
Medtronic SHS (MDT) | 1.3 | $88M | +3% | 1.0M | 87.15 |
|
Sage Therapeutics (SAGE) | 1.3 | $84M | +27% | 4.5M | 18.74 |
|
EXACT Sciences Corporation (EXAS) | 1.2 | $79M | +8% | 1.1M | 69.06 |
|
UnitedHealth (UNH) | 1.1 | $74M | +7% | 149k | 494.70 |
|
Tandem Diabetes Care Com New (TNDM) | 1.1 | $72M | 2.0M | 35.41 |
|
|
Essa Pharma Com New (EPIX) | 1.0 | $67M | 7.9M | 8.49 |
|
|
Immunocore Hldgs Ads (IMCR) | 1.0 | $63M | 972k | 65.00 |
|
|
Biohaven (BHVN) | 1.0 | $63M | +6% | 1.2M | 54.69 |
|
Option Care Health Com New (OPCH) | 1.0 | $63M | -3% | 1.9M | 33.54 |
|
Charles River Laboratories (CRL) | 0.9 | $62M | +5% | 230k | 270.95 |
|
Insmed Com Par $.01 (INSM) | 0.9 | $58M | -6% | 2.1M | 27.13 |
|
Axsome Therapeutics (AXSM) | 0.8 | $55M | +7% | 686k | 79.80 |
|
Bio Rad Labs Cl A (BIO) | 0.8 | $54M | +10% | 157k | 345.87 |
|
Hca Holdings (HCA) | 0.8 | $53M | +4% | 160k | 333.53 |
|
Anthem (ELV) | 0.8 | $51M | -8% | 99k | 518.54 |
|
Align Technology (ALGN) | 0.8 | $51M | -2% | 155k | 327.92 |
|
IDEXX Laboratories (IDXX) | 0.8 | $50M | 93k | 539.93 |
|
|
Insulet Corporation (PODD) | 0.8 | $50M | 294k | 171.40 |
|
|
Accolade (ACCD) | 0.8 | $50M | +6% | 4.8M | 10.48 |
|
Relay Therapeutics (RLAY) | 0.8 | $49M | 5.9M | 8.30 |
|
|
Evolent Health Cl A (EVH) | 0.7 | $49M | -37% | 1.5M | 32.79 |
|
Humana (HUM) | 0.7 | $47M | +34% | 136k | 346.72 |
|
Inspire Med Sys (INSP) | 0.7 | $47M | 218k | 214.79 |
|
|
Ge Healthcare Technologies I Common Stock (GEHC) | 0.7 | $47M | -4% | 512k | 90.91 |
|
Exelixis (EXEL) | 0.7 | $45M | -9% | 1.9M | 23.73 |
|
Eli Lilly & Co. (LLY) | 0.7 | $45M | +3% | 58k | 777.96 |
|
Procept Biorobotics Corp (PRCT) | 0.7 | $44M | 890k | 49.42 |
|
|
Black Diamond Therapeutics (BDTX) | 0.7 | $43M | 8.5M | 5.07 |
|
|
Crispr Therapeutics Namen Akt (CRSP) | 0.6 | $42M | -31% | 620k | 68.16 |
|
Caredx (CDNA) | 0.6 | $42M | 3.9M | 10.59 |
|
|
Molina Healthcare (MOH) | 0.6 | $41M | +9% | 100k | 410.83 |
|
Merck & Co (MRK) | 0.6 | $41M | +7% | 311k | 131.95 |
|
Penumbra (PEN) | 0.6 | $40M | -10% | 181k | 223.18 |
|
Cooper Cos (COO) | 0.6 | $40M | NEW | 397k | 101.46 |
|
Beam Therapeutics (BEAM) | 0.6 | $39M | +71% | 1.2M | 33.04 |
|
Veeva Sys Cl A Com (VEEV) | 0.6 | $39M | -13% | 168k | 231.69 |
|
Scholar Rock Hldg Corp (SRRK) | 0.6 | $39M | 2.2M | 17.76 |
|
|
Zimmer Holdings (ZBH) | 0.6 | $37M | 282k | 131.98 |
|
|
Fate Therapeutics (FATE) | 0.5 | $36M | 4.8M | 7.34 |
|
|
Shockwave Med | 0.5 | $34M | -15% | 106k | 325.63 |
|
Sarepta Therapeutics (SRPT) | 0.5 | $33M | +5% | 252k | 129.46 |
|
AmerisourceBergen (COR) | 0.5 | $32M | +4% | 132k | 242.99 |
|
Globus Med Cl A (GMED) | 0.5 | $31M | -4% | 580k | 53.64 |
|
Cigna Corp (CI) | 0.4 | $29M | -9% | 80k | 363.19 |
|
Centene Corporation (CNC) | 0.4 | $29M | -17% | 363k | 78.48 |
|
BioMarin Pharmaceutical (BMRN) | 0.4 | $28M | 322k | 87.34 |
|
|
Apellis Pharmaceuticals (APLS) | 0.4 | $28M | -42% | 474k | 58.78 |
|
Silk Road Medical Inc Common (SILK) | 0.4 | $28M | +5% | 1.5M | 18.32 |
|
Castle Biosciences (CSTL) | 0.4 | $27M | 1.2M | 22.15 |
|
|
Transmedics Group (TMDX) | 0.4 | $27M | -29% | 364k | 73.94 |
|
Esperion Therapeutics (ESPR) | 0.4 | $27M | +136% | 9.9M | 2.68 |
|
Wave Life Sciences SHS (WVE) | 0.4 | $25M | -8% | 4.1M | 6.17 |
|
Natera (NTRA) | 0.4 | $25M | +5% | 270k | 91.46 |
|
Thermo Fisher Scientific (TMO) | 0.4 | $23M | +13% | 40k | 581.21 |
|
Hologic (HOLX) | 0.3 | $23M | 290k | 77.96 |
|
|
Danaher Corporation (DHR) | 0.3 | $22M | +2% | 86k | 249.72 |
|
Privia Health Group (PRVA) | 0.3 | $21M | 1.1M | 19.59 |
|
|
Hutchmed China Sponsored Ads (HCM) | 0.3 | $19M | +2% | 1.2M | 16.80 |
|
Si-bone (SIBN) | 0.3 | $19M | +810% | 1.1M | 16.37 |
|
Verona Pharma Sponsored Ads (VRNA) | 0.3 | $18M | +35% | 1.1M | 16.09 |
|
Pacific Biosciences of California (PACB) | 0.3 | $17M | -37% | 4.6M | 3.75 |
|
Steris Shs Usd (STE) | 0.3 | $17M | NEW | 73k | 224.82 |
|
Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $16M | +45% | 293k | 56.09 |
|
Generation Bio (GBIO) | 0.2 | $16M | +6% | 3.9M | 4.07 |
|
Annexon (ANNX) | 0.2 | $16M | NEW | 2.2M | 7.17 |
|
Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $16M | +2858% | 364k | 42.86 |
|
Neogenomics Com New (NEO) | 0.2 | $15M | NEW | 946k | 15.72 |
|
AtriCure (ATRC) | 0.2 | $14M | -45% | 447k | 30.42 |
|
10x Genomics Cl A Com (TXG) | 0.2 | $12M | +5% | 308k | 37.53 |
|
Phreesia (PHR) | 0.2 | $11M | +5% | 443k | 23.93 |
|
Omnicell (OMCL) | 0.1 | $6.9M | +5% | 235k | 29.23 |
|
Regeneron Pharmaceuticals (REGN) | 0.1 | $6.8M | -33% | 7.1k | 962.49 |
|
Amgen (AMGN) | 0.1 | $6.3M | -35% | 22k | 284.32 |
|
ResMed (RMD) | 0.1 | $6.0M | 30k | 198.03 |
|
|
Illumina (ILMN) | 0.1 | $6.0M | -3% | 44k | 137.32 |
|
Glaukos (GKOS) | 0.1 | $5.3M | NEW | 56k | 94.29 |
|
Abbvie (ABBV) | 0.1 | $5.0M | +310% | 28k | 182.10 |
|
McKesson Corporation (MCK) | 0.1 | $4.8M | +85% | 9.0k | 536.85 |
|
Recursion Pharmaceuticals In Cl A (RXRX) | 0.1 | $4.2M | +143% | 425k | 9.97 |
|
Teladoc (TDOC) | 0.1 | $4.1M | +5% | 273k | 15.10 |
|
Beigene Sponsored Adr (BGNE) | 0.1 | $3.9M | -12% | 25k | 156.39 |
|
Doximity Cl A (DOCS) | 0.1 | $3.9M | -45% | 144k | 26.91 |
|
Spdr S&p 500 Etf Tr Tr Unit (SPY) | 0.1 | $3.5M | +156% | 6.7k | 523.07 |
|
Dr Reddys Labs Adr (RDY) | 0.0 | $3.0M | -32% | 41k | 73.35 |
|
Gilead Sciences (GILD) | 0.0 | $2.4M | -35% | 33k | 73.25 |
|
Molecular Templates Com New (MTEM) | 0.0 | $2.3M | 1.0M | 2.24 |
|
|
Iqvia Holdings (IQV) | 0.0 | $2.1M | 8.3k | 252.89 |
|
|
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.0 | $2.0M | NEW | 142k | 14.11 |
|
Nevro (NVRO) | 0.0 | $2.0M | -31% | 135k | 14.44 |
|
CVS Caremark Corporation (CVS) | 0.0 | $1.8M | -29% | 22k | 79.76 |
|
Certara Ord (CERT) | 0.0 | $1.7M | +5% | 96k | 17.88 |
|
Astrazeneca Sponsored Adr (AZN) | 0.0 | $1.6M | -55% | 23k | 67.75 |
|
Biogen Idec (BIIB) | 0.0 | $1.3M | -29% | 6.0k | 215.63 |
|
Bristol Myers Squibb (BMY) | 0.0 | $1.3M | NEW | 23k | 54.23 |
|
Zoetis Cl A (ZTS) | 0.0 | $1.3M | +29% | 7.5k | 169.21 |
|
Outset Med (OM) | 0.0 | $1.3M | -67% | 572k | 2.22 |
|
Encompass Health Corp (EHC) | 0.0 | $1.2M | +25% | 15k | 82.58 |
|
Cytokinetics Com New (CYTK) | 0.0 | $1.1M | -17% | 16k | 70.11 |
|
Vaneck Etf Trust Gold Miners Etf (GDX) | 0.0 | $1.0M | 33k | 31.62 |
|
|
Johnson & Johnson (JNJ) | 0.0 | $1.0M | -77% | 6.4k | 158.19 |
|
Pfizer (PFE) | 0.0 | $939k | +47% | 34k | 27.75 |
|
Alphabet Cap Stk Cl C (GOOG) | 0.0 | $914k | 6.0k | 152.26 |
|
|
Vaxcyte (PCVX) | 0.0 | $905k | -16% | 13k | 68.31 |
|
Krystal Biotech (KRYS) | 0.0 | $856k | -39% | 4.8k | 177.93 |
|
Alkermes SHS (ALKS) | 0.0 | $654k | -53% | 24k | 27.07 |
|
Xenon Pharmaceuticals (XENE) | 0.0 | $607k | -35% | 14k | 43.05 |
|
Protagonist Therapeutics (PTGX) | 0.0 | $554k | -36% | 19k | 28.93 |
|
Rhythm Pharmaceuticals (RYTM) | 0.0 | $542k | -61% | 13k | 43.33 |
|
Rocket Pharmaceuticals (RCKT) | 0.0 | $531k | -6% | 20k | 26.94 |
|
4d Molecular Therapeutics In (FDMT) | 0.0 | $500k | NEW | 16k | 31.86 |
|
Blueprint Medicines (BPMC) | 0.0 | $484k | NEW | 5.1k | 94.86 |
|
C4 Therapeutics Com Stk (CCCC) | 0.0 | $471k | -7% | 58k | 8.17 |
|
Tenet Healthcare Corp Com New (THC) | 0.0 | $446k | +193% | 4.2k | 105.11 |
|
Viking Therapeutics (VKTX) | 0.0 | $443k | -69% | 5.4k | 82.00 |
|
Merus N V (MRUS) | 0.0 | $441k | -56% | 9.8k | 45.03 |
|
Astrana Health Com New (ASTH) | 0.0 | $431k | NEW | 10k | 41.99 |
|
Garmin SHS (GRMN) | 0.0 | $417k | NEW | 2.8k | 148.87 |
|
Bridgebio Pharma (BBIO) | 0.0 | $396k | -61% | 13k | 30.92 |
|
Verve Therapeutics (VERV) | 0.0 | $388k | -25% | 29k | 13.28 |
|
Apple (AAPL) | 0.0 | $377k | NEW | 2.2k | 171.48 |
|
West Pharmaceutical Services (WST) | 0.0 | $344k | NEW | 870.00 | 395.71 |
|
Dynavax Technologies Corp Com New (DVAX) | 0.0 | $342k | -36% | 28k | 12.41 |
|
Cardinal Health (CAH) | 0.0 | $336k | -14% | 3.0k | 111.90 |
|
Miragen Therapeutics (VRDN) | 0.0 | $334k | -36% | 19k | 17.51 |
|
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.0 | $311k | -37% | 13k | 24.90 |
|
Madrigal Pharmaceuticals (MDGL) | 0.0 | $283k | NEW | 1.1k | 267.04 |
|
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.0 | $275k | +78% | 45k | 6.06 |
|
Adma Biologics (ADMA) | 0.0 | $270k | NEW | 41k | 6.60 |
|
Simply Good Foods (SMPL) | 0.0 | $269k | NEW | 7.9k | 34.03 |
|
Biomea Fusion (BMEA) | 0.0 | $266k | -28% | 18k | 14.95 |
|
Regenxbio Inc equity us cm (RGNX) | 0.0 | $253k | NEW | 12k | 21.07 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.0 | $221k | NEW | 4.4k | 50.23 |
|
Baidu Spon Adr Rep A (BIDU) | 0.0 | $211k | NEW | 2.0k | 105.28 |
|
Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $207k | -35% | 33k | 6.38 |
|
Baxter International (BAX) | 0.0 | $180k | NEW | 4.2k | 42.74 |
|
Viatris (VTRS) | 0.0 | $173k | -19% | 15k | 11.94 |
|
89bio (ETNB) | 0.0 | $160k | -32% | 14k | 11.64 |
|
Ideaya Biosciences (IDYA) | 0.0 | $145k | NEW | 3.3k | 43.88 |
|
Mineralys Therapeutics (MLYS) | 0.0 | $119k | NEW | 9.2k | 12.91 |
|
NVIDIA Corporation (NVDA) | 0.0 | $88k | -2% | 97.00 | 903.56 |
|
Qualcomm (QCOM) | 0.0 | $88k | +48% | 517.00 | 169.30 |
|
Oracle Corporation (ORCL) | 0.0 | $85k | +49% | 677.00 | 125.61 |
|
Agilent Technologies Inc C ommon (A) | 0.0 | $79k | +48% | 540.00 | 145.51 |
|
Microsoft Corporation (MSFT) | 0.0 | $76k | +47% | 180.00 | 420.72 |
|
Omniab (OABI) | 0.0 | $62k | NEW | 12k | 5.42 |
|
Mettler-Toledo International (MTD) | 0.0 | $44k | +32% | 33.00 | 1331.30 |
|
Laboratory Corp Amer Hldgs Com New | 0.0 | $32k | -97% | 148.00 | 218.46 |
|
Exscientia Ads (EXAI) | 0.0 | $15k | +49% | 2.6k | 5.72 |
|
Ionq Inc Pipe (IONQ) | 0.0 | $11k | +49% | 1.1k | 9.99 |
|
Past Filings by Bellevue Group
SEC 13F filings are viewable for Bellevue Group going back to 2016
- Bellevue Group 2024 Q1 filed May 15, 2024
- Bellevue Group 2023 Q4 filed Feb. 14, 2024
- Bellevue Group 2023 Q3 filed Nov. 14, 2023
- Bellevue Group 2023 Q2 filed Aug. 14, 2023
- Bellevue Group 2023 Q1 filed May 15, 2023
- Bellevue Group 2022 Q4 filed Feb. 14, 2023
- Bellevue Group 2022 Q3 filed Nov. 14, 2022
- Bellevue Group 2022 Q2 filed Aug. 11, 2022
- Bellevue Group 2022 Q1 filed May 13, 2022
- Bellevue Group 2021 Q4 filed Feb. 10, 2022
- Bellevue Group 2021 Q3 filed Nov. 12, 2021
- Bellevue Group 2021 Q2 filed Aug. 12, 2021
- Bellevue Group 2021 Q1 filed May 12, 2021
- Bellevue Group 2020 Q4 filed Feb. 16, 2021
- Bellevue Group 2020 Q3 filed Nov. 16, 2020
- Bellevue Group 2020 Q2 filed Aug. 13, 2020